243 related articles for article (PubMed ID: 17920166)
1. A genetically engineered prime-boost vaccination strategy for oculonasal delivery with poly(D,L-lactic-co-glycolic acid) microparticles against infection of turkeys with avian Metapneumovirus.
Liman M; Peiser L; Zimmer G; Pröpsting M; Naim HY; Rautenschlein S
Vaccine; 2007 Nov; 25(46):7914-26. PubMed ID: 17920166
[TBL] [Abstract][Full Text] [Related]
2. Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys.
Hu H; Roth JP; Estevez CN; Zsak L; Liu B; Yu Q
Vaccine; 2011 Nov; 29(47):8624-33. PubMed ID: 21925228
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of commercial broiler chicks against avian metapneumovirus infection: a comparison of drinking-water, spray and oculo-oral delivery methods.
Ganapathy K; Bufton A; Pearson A; Lemiere S; Jones RC
Vaccine; 2010 May; 28(23):3944-8. PubMed ID: 20392431
[TBL] [Abstract][Full Text] [Related]
4. Investigations on the protective role of passively transferred antibodies against avian metapneumovirus infection in turkeys.
Rubbenstroth D; Rautenschlein S
Avian Pathol; 2009 Dec; 38(6):427-36. PubMed ID: 19937531
[TBL] [Abstract][Full Text] [Related]
5. Protection against avian metapneumovirus subtype C in turkeys immunized via the respiratory tract with inactivated virus.
Cha RM; Khatri M; Sharma JM
Vaccine; 2011 Jan; 29(3):459-65. PubMed ID: 21073989
[TBL] [Abstract][Full Text] [Related]
6. Avian metapneumovirus excretion in vaccinated and non-vaccinated specified pathogen free laying chickens.
Hess M; Huggins MB; Mudzamiri R; Heincz U
Avian Pathol; 2004 Feb; 33(1):35-40. PubMed ID: 14681066
[TBL] [Abstract][Full Text] [Related]
7. Immunization of turkeys with a DNA vaccine expressing either the F or N gene of avian metapneumovirus.
Kapczynski DR; Sellers HS
Avian Dis; 2003; 47(4):1376-83. PubMed ID: 14708985
[TBL] [Abstract][Full Text] [Related]
8. Protection by recombinant viral proteins against a respiratory challenge with virulent avian metapneumovirus.
Chary P; Njenga MK; Sharma JM
Vet Immunol Immunopathol; 2005 Dec; 108(3-4):427-32. PubMed ID: 16112741
[TBL] [Abstract][Full Text] [Related]
9. Development of a virosome vaccine against avian metapneumovirus subtype C for protection in turkeys.
Kapczynski DR
Avian Dis; 2004; 48(2):332-43. PubMed ID: 15283420
[TBL] [Abstract][Full Text] [Related]
10. Duration of immunity produced by a live attenuated vaccine against avian pneumovirus type C.
Patnayak DP; Goyal SM
Avian Pathol; 2004 Oct; 33(5):465-9. PubMed ID: 15545025
[TBL] [Abstract][Full Text] [Related]
11. Onset of immunity following in ovo delivery of avian metapneumovirus vaccines.
Tarpey I; Huggins MB
Vet Microbiol; 2007 Sep; 124(1-2):134-9. PubMed ID: 17462834
[TBL] [Abstract][Full Text] [Related]
12. Development of vaccine-induced immunity against TRT in turkeys depends remarkably on the level of maternal antibodies and the age of birds on the day of vaccination.
Smialek M; Pestka D; Tykalowski B; Stenzel T; Koncicki A
BMC Vet Res; 2015 Feb; 11():28. PubMed ID: 25889279
[TBL] [Abstract][Full Text] [Related]
13. Engineered Newcastle disease virus expressing the F and G proteins of AMPV-C confers protection against challenges in turkeys.
Hu H; Roth JP; Zsak L; Yu Q
Sci Rep; 2017 Jun; 7(1):4025. PubMed ID: 28642611
[TBL] [Abstract][Full Text] [Related]
14. A wild goose metapneumovirus containing a large attachment glycoprotein is avirulent but immunoprotective in domestic turkeys.
Bennett RS; LaRue R; Shaw D; Yu Q; Nagaraja KV; Halvorson DA; Njenga MK
J Virol; 2005 Dec; 79(23):14834-42. PubMed ID: 16282483
[TBL] [Abstract][Full Text] [Related]
15. Induction of local and systemic immune reactions following infection of turkeys with avian Metapneumovirus (aMPV) subtypes A and B.
Liman M; Rautenschlein S
Vet Immunol Immunopathol; 2007 Feb; 115(3-4):273-85. PubMed ID: 17207537
[TBL] [Abstract][Full Text] [Related]
16. Charged amino acids in the AMPV fusion protein have more influence on induced protection than deletion of the SH or G genes.
Naylor CJ; Lupini C; Brown PA
Vaccine; 2010 Sep; 28(41):6800-7. PubMed ID: 20656031
[TBL] [Abstract][Full Text] [Related]
17. Development of a vaccine-challenge model for avian metapneumovirus subtype C in turkeys.
Velayudhan BT; Noll SL; Thachil AJ; Shaw DP; Goyal SM; Halvorson DA; Nagaraja KV
Vaccine; 2007 Feb; 25(10):1841-7. PubMed ID: 17229500
[TBL] [Abstract][Full Text] [Related]
18. Effects of cyclosporin A induced T-lymphocyte depletion on the course of avian Metapneumovirus (aMPV) infection in turkeys.
Rubbenstroth D; Dalgaard TS; Kothlow S; Juul-Madsen HR; Rautenschlein S
Dev Comp Immunol; 2010 May; 34(5):518-29. PubMed ID: 20043941
[TBL] [Abstract][Full Text] [Related]
19. Generation and biological assessment of recombinant avian metapneumovirus subgroup C (aMPV-C) viruses containing different length of the G gene.
Yu Q; Estevez C; Song M; Kapczynski D; Zsak L
Virus Res; 2010 Feb; 147(2):182-8. PubMed ID: 19891997
[TBL] [Abstract][Full Text] [Related]
20. Protection in specific pathogen free chickens with live avian metapneumovirus and Newcastle disease virus vaccines applied singly or in combination.
Ganapathy K; Cox WJ; Gough RE; Cargill P; Montiel E; Jones RC
Avian Pathol; 2007 Aug; 36(4):313-7. PubMed ID: 17620178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
